Literature DB >> 15816364

B-type natriuretic peptide in patients with clinical hyperthyroidism.

T Wei1, C Zeng, Y Tian, Q Chen, L Wang.   

Abstract

AIMS: To investigate the level and clinical significance of plasma B-type natriuretic peptide (BNP) in patients with hyperthyroidism.
METHODS: Plasma BNP was measured in 32 healthy subjects and 67 patients with clinical hyperthyroidism. Left ventricular anatomy and function was assessed with echocardiography.
RESULTS: The average BNP in hyperthyroid patients was higher than that in healthy subjects (186+/-140 vs 34+/-17 ng/l, p =0.001). The increase in BNP was mainly found in hyperthyroid patients who had clinical and echocardiographic evidence of left ventricular dysfunction (250+/-190 ng/l). The BNP level in patients with hyperthyroidism, but with normal left ventricular function, was similar to that of the controls (37+/-17 vs 34+/-17, ng/l, p>0.05). Multi-regression analysis showed that left atrial diameter and left ventricular ejection fraction were independently associated with the plasma levels of BNP.
CONCLUSIONS: there is a significant elevation in plasma BNP in patients with hyperthyroidism; the increase is largely due to hyperthyroidism-induced left ventricular dysfunction. Measurements of plasma BNP may help to detect heart failure in patients with clinical hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15816364     DOI: 10.1007/bf03345522

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  Graves' disease. Influence of age on clinical findings.

Authors:  R A Nordyke; F I Gilbert; A S Harada
Journal:  Arch Intern Med       Date:  1988-03

Review 3.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

4.  Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients.

Authors:  Tiemin Wei; Chunlai Zeng; Liping Chen; Qunying Chen; Ruiying Zhao; Ganxin Lu; Chunling Lu; Lexin Wang
Journal:  Eur J Heart Fail       Date:  2005-01       Impact factor: 15.534

Review 5.  Severe reversible dilated cardiomyopathy and hyperthyroidism: case report and review of the literature.

Authors:  Cristina Boccalandro; Fernando Boccalandro; Philip Orlander; Chik Fong Wei
Journal:  Endocr Pract       Date:  2003 Mar-Apr       Impact factor: 3.443

6.  Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation.

Authors:  Beata Wozakowska-Kapłon
Journal:  Am J Cardiol       Date:  2004-06-15       Impact factor: 2.778

7.  N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states.

Authors:  Marianne Schultz; Jens Faber; Caroline Kistorp; Anne Jarløv; Frants Pedersen; Niels Wiinberg; Per Hildebrandt
Journal:  Clin Endocrinol (Oxf)       Date:  2004-01       Impact factor: 3.478

8.  Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.

Authors:  M R Cowie; A D Struthers; D A Wood; A J Coats; S G Thompson; P A Poole-Wilson; G C Sutton
Journal:  Lancet       Date:  1997-11-08       Impact factor: 79.321

Review 9.  Hyperthyroidism: a "curable" cause of congestive heart failure--three case reports and a review of the literature.

Authors:  Kamran Riaz; Alan D Forker; William L Isley; Mitchell S Hamburg; Peter A McCullough
Journal:  Congest Heart Fail       Date:  2003 Jan-Feb

10.  Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy.

Authors:  J C Forfar; A L Muir; S A Sawers; A D Toft
Journal:  N Engl J Med       Date:  1982-11-04       Impact factor: 91.245

View more
  5 in total

Review 1.  Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future.

Authors:  Farah Omran; Ioannis Kyrou; Faizel Osman; Ven Gee Lim; Harpal Singh Randeva; Kamaljit Chatha
Journal:  Int J Mol Sci       Date:  2022-05-19       Impact factor: 6.208

Review 2.  Interpretation and use of natriuretic peptides in non-congestive heart failure settings.

Authors:  Shih-Hung Tsai; Yen-Yue Lin; Shi-Jye Chu; Ching-Wang Hsu; Shu-Meng Cheng
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

3.  Serum levels of N-terminal pro-B-type natriuretic peptide are associated with allograft function in recipients of renal transplants.

Authors:  Gerd Bodlaj; Rainer Hubmann; Karim Saleh; Georg Biesenbach; Erich Pohanka; Tatjana Stojakovic; Jörg Berg
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

4.  Natriuretic peptides: Diagnostic and therapeutic use.

Authors:  Kaushik Pandit; Pradip Mukhopadhyay; Sujoy Ghosh; Subhankar Chowdhury
Journal:  Indian J Endocrinol Metab       Date:  2011-10

5.  BNP as a New Biomarker of Cardiac Thyroid Hormone Function.

Authors:  Kaihao Wang; Kaie Ojamaa; Abigail Samuels; Nimra Gilani; Kuo Zhang; Shimin An; Youhua Zhang; Yi-Da Tang; Bardia Askari; Anthony Martin Gerdes
Journal:  Front Physiol       Date:  2020-07-09       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.